These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12459506)

  • 21. Region-dependent G-protein activation by mu-, delta 1- and delta 2-opioid receptor agonists in the brain: comparison between the midbrain and forebrain.
    Tsuji M; Narita M; Mizoguchi H; Narita M; Ohsawa M; Kamei J; Nagase H; Takeda H; Matsumiya T; Tseng LF
    Life Sci; 1999; 65(16):PL233-9. PubMed ID: 10573190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific activation of the mu opioid receptor (MOR) by endomorphin 1 and endomorphin 2.
    Monory K; Bourin MC; Spetea M; Tömböly C; Tóth G; Matthes HW; Kieffer BL; Hanoune J; Borsodi A
    Eur J Neurosci; 2000 Feb; 12(2):577-84. PubMed ID: 10712637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of G-protein activation in the brain by mu-, delta-, and kappa-opioid receptor agonists in mu-opioid receptor knockout mice.
    Park Y; Ma T; Tanaka S; Jang C; Loh HH; Ko KH; Ho IK
    Brain Res Bull; 2000 Jul; 52(4):297-302. PubMed ID: 10856828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory function in adult mice lacking the mu-opioid receptor: role of delta-receptors.
    Morin-Surun MP; Boudinot E; Dubois C; Matthes HW; Kieffer BL; Denavit-Saubié M; Champagnat J; Foutz AS
    Eur J Neurosci; 2001 May; 13(9):1703-10. PubMed ID: 11359522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mu opioid receptor activation enhances regulator of G protein signaling 4 association with the mu opioid receptor/G protein complex in a GTP-dependent manner.
    Santhappan R; Crowder AT; Gouty S; Cox BM; Côté TE
    J Neurochem; 2015 Oct; 135(1):76-87. PubMed ID: 26119705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endomorphin-1 and endomorphin-2 are partial agonists at the human mu-opioid receptor.
    Hosohata K; Burkey TH; Alfaro-Lopez J; Varga E; Hruby VJ; Roeske WR; Yamamura HI
    Eur J Pharmacol; 1998 Apr; 346(1):111-4. PubMed ID: 9617760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
    Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice.
    Hosohata Y; Vanderah TW; Burkey TH; Ossipov MH; Kovelowski CJ; Sora I; Uhl GR; Zhang X; Rice KC; Roeske WR; Hruby VJ; Yamamura HI; Lai J; Porreca F
    Eur J Pharmacol; 2000 Feb; 388(3):241-8. PubMed ID: 10675732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists.
    Traynor JR; Clark MJ; Remmers AE
    J Pharmacol Exp Ther; 2002 Jan; 300(1):157-61. PubMed ID: 11752111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
    Liu JG; Prather PL
    Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.
    Hahn YK; Paris JJ; Lichtman AH; Hauser KF; Sim-Selley LJ; Selley DE; Knapp PE
    Neurobiol Dis; 2016 Aug; 92(Pt B):124-36. PubMed ID: 26845176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleoside diphosphate kinase associated with membranes modulates mu-opioid receptor-mediated [35S]GTPgammaS binding and agonist binding to mu-opioid receptor.
    Zhang D; Li JG; Chen C; Liu-Chen LY
    Eur J Pharmacol; 1999 Jul; 377(2-3):223-31. PubMed ID: 10456435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
    Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
    J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G Proteins in the amygdala of fawn-hooded rats.
    Chen F; Lawrence AJ
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1020-6. PubMed ID: 15121763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of mu-opioid receptor clone leads to differential loss of spinal endomorphin-1-and endomorphin-2-induced antinociception in the mouse.
    Wu HE; Mizoguchi H; Terashvili M; Leitermann RJ; Hung KC; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2002 Nov; 303(2):867-73. PubMed ID: 12388674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions.
    Maher CE; Selley DE; Childers SR
    Biochem Pharmacol; 2000 Jun; 59(11):1395-401. PubMed ID: 10751548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation by neuropeptide FF of the interaction of mu-opioid (MOP) receptor with G-proteins.
    Kersanté F; Moulédous L; Zajac JM; Mollereau C
    Neurochem Int; 2010; 56(6-7):768-73. PubMed ID: 20211672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of endomorphin-1 and -2 on [35S]GTPgammaS binding in the mouse spinal cord.
    Narita M; Mizoguchi H; Oji GS; Tseng EL; Suganuma C; Nagase H; Tseng LF
    Eur J Pharmacol; 1998 Jun; 351(3):383-7. PubMed ID: 9721032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy.
    Clayton CC; Bruchas MR; Lee ML; Chavkin C
    Mol Pharmacol; 2010 Mar; 77(3):339-47. PubMed ID: 19959593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.